AGM-130
/ AnyGen
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 15, 2023
Theoretical characterization and biological activity investigation of indirubins, cyclin dependent kinases inhibitors.
(PubMed, J Biomol Struct Dyn)
- "Results analysis indicated that extra interaction sites were provided through the set of substitutions in compounds (1): Indirubin-3'-monoxime, (2): Indirubin-5-sulfonic acid, (3): 5-Nitro-indirubinoxime, (4): 5'-OH-5-nitro-indirubinoxime (AGM130), (5): 7-Bromo-5'-carboxyindirubin-3'-oxime, and (6): 7 BIO and consequently, extra hydrogen bonds may be formed with the active sites of molecular targets, such as GSK-3, CDKs, and Aurora kinases, as well as the aryl hydrocarbon receptor...Two phototoxic brominated compounds showed important absorption spectra modifications. It was also found that the main absorption bands of all compounds derived from π→π*(HOMO→LUMO) transitions.Communicated by Ramaswamy H. Sarma."
Journal
1 to 1
Of
1
Go to page
1